Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
665-01-013 ISMRM Abstract

Identifying Risk Factors for Cancer-Related Cognitive Decline using Multimodal MRI

Primary: Neuro - Other Neurodegeneration
Secondary: Analysis Methods - Classification and Prediction
665-01-013 · fMRI: Applications in Neurology and Psychiatry I · Thursday, 14 May, 8:30 AM–9:25 AM · Digital Posters Row F
Keywords: Breast cancer Predictive model Multi-modal MRI Cognitive decline Risk factors
Accepted
Rob Colaes 1,2,3, Gwen Schroyen1, Ahmed M Radwan1,2,4, Rebeca Alejandra Gavrila Laic1, Charlotte Sleurs5,6,7,8, Shannon Helsper1, Uwe Himmelreich1, Sigrid Hatse3,7, Ann Smeets3,7,9, Sabine Deprez1,2,3, Stefan Sunaert1,2,4
1Department of Imaging & Pathology, KU Leuven, Leuven, Belgium
2Leuven Brain Institute, KU Leuven, Leuven, Belgium
3Leuven Cancer Institute, KU Leuven, Leuven, Belgium
4Department of Radiology, UZ Leuven, Leuven, Belgium
5Tilburg University, Tilburg, Netherlands
6KU Leuven, Leuven, Belgium
7Department of Oncology, KU Leuven, Leuven, Belgium
8Department of Neuropsychology, Tilburg University, Tilburg, Netherlands
9Department of Oncology, Surgical Oncology, UZ Leuven, Leuven, Belgium
Presenting Author: Rob Colaes

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Dijkshoorn ABC, van Stralen HE, Sloots M, Schagen SB, Visser-Meily JMA, Schepers VPM. Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies. Psychooncology. 2021;30(5):635-648. doi:10.1002/pon.5623 [doi]
2. Duan R, Wen Z, Zhang T, Liu J, Feng T, Ren T. Advances in risk prediction models for cancer-related cognitive impairment. Clin Exp Med. 2025;25(1):74. doi:10.1007/s10238-025-01590-6 [doi]
3. Zhou Z, Ren J, Liu Q, et al. A nomogram for predicting the risk of cancer-related cognitive impairment in breast cancer patients based on a scientific symptom model. Sci Rep. 2024;14(1):14566. doi:10.1038/s41598-024-65406-5 [doi]
4. McDeed AP, Van Dyk K, Zhou X, et al. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study. JNCI Cancer Spectr. 2024;8(2). doi:10.1093/jncics/pkae019 [doi]
5. Duivon M, Lequesne J, Di Meglio A, et al. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study. Breast Cancer Res. 2024;26(1):93. doi:10.1186/s13058-024-01850-5 [doi]
6. de Ruiter MB, Reneman L, Kieffer JM, Oldenburg HSA, Schagen SB. Brain white matter microstructure as a risk factor for cognitive decline after chemotherapy for breast cancer. J Clin Oncol. 2021;39(35):3908-3917. doi:10.1200/JCO.21.00627 [doi]
7. Kesler SR, Rao A, Blayney DW, Oakley-Girvan IA, Karuturi M, Palesh O. Predicting long-term cognitive outcome following breast cancer with pre-treatment resting state fMRI and random forest machine learning. Front Hum Neurosci. 2017;11:555. doi:10.3389/fnhum.2017.00555 [doi]
8. Henschel L, Conjeti S, Estrada S, Diers K, Fischl B, Reuter M. FastSurfer - A fast and accurate deep learning based neuroimaging pipeline. Neuroimage. 2020;219(117012):117012. doi:10.1016/j.neuroimage.2020.117012 [doi]
9. Rakić M, Vercruyssen S, Van Eyndhoven S, et al. icobrain ms 5.1: Combining unsupervised and supervised approaches for improving the detection of multiple sclerosis lesions. NeuroImage Clin. 2021;31(102707):102707. doi:10.1016/j.nicl.2021.102707 [doi]
10. Jain S, Sima DM, Ribbens A, et al. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. NeuroImage Clin. 2015;8:367-375. doi:10.1016/j.nicl.2015.05.003 [doi]
11. Oeltzschner G, Zöllner HJ, Hui SCN, et al. Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. J Neurosci Methods. 2020;343(108827):108827. doi:10.1016/j.jneumeth.2020.108827 [doi]
12. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14(4):260-264. doi:10.1002/nbm.698 [doi]
13. Esteban O, Markiewicz CJ, Blair RW, et al. fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods. 2019;16(1):111-116. doi:10.1038/s41592-018-0235-4 [doi]
14. Tournier JD, Smith R, Raffelt D, et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage. 2019;202(116137):116137. doi:10.1016/j.neuroimage.2019.116137 [doi]
15. Lundberg SM, Lee SI. A unified approach to interpreting model predic- tions. Adv Neur In. Published online 2017.
16. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448-460. https://www.ncbi.nlm.nih.gov/pubmed/11939702 [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/665-01-013